Cardinal Point Capital Management ULC grew its holdings in Oracle Corporation (NYSE:ORCL – Free Report) by 5.8% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 74,358 shares of the enterprise software provider’s stock after acquiring an additional 4,102 shares during the quarter. Cardinal Point Capital Management ULC’s holdings in Oracle were worth $10,209,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also made changes to their positions in ORCL. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in shares of Oracle during the second quarter worth about $625,454,000. Edmond DE Rothschild Holding S.A. lifted its holdings in shares of Oracle by 8.7% in the 2nd quarter. Edmond DE Rothschild Holding S.A. now owns 79,008 shares of the enterprise software provider’s stock valued at $11,579,000 after purchasing an additional 6,296 shares during the last quarter. Generate Investment Management Ltd lifted its holdings in shares of Oracle by 178.4% in the 3rd quarter. Generate Investment Management Ltd now owns 407,314 shares of the enterprise software provider’s stock valued at $55,924,000 after purchasing an additional 261,019 shares during the last quarter. Verus Wealth Management LLC purchased a new stake in shares of Oracle in the 3rd quarter valued at about $1,365,000. Finally, Sawyer & Company Inc acquired a new stake in shares of Oracle in the 3rd quarter valued at about $8,243,000. Institutional investors and hedge funds own 42.44% of the company’s stock.
Oracle Stock Performance
NYSE ORCL opened at $129.10 on Thursday. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 1.89. Oracle Corporation has a 52-week low of $114.50 and a 52-week high of $287.19. The business’s 50-day moving average price is $144.17 and its 200 day moving average price is $158.44. The firm has a market cap of $390.36 billion, a P/E ratio of 20.24, a P/E/G ratio of 0.93 and a beta of 1.78.
Oracle Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, October 23rd. Shareholders of record on Friday, October 9th will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.5%. The ex-dividend date is Friday, October 9th. Oracle’s dividend payout ratio (DPR) is 31.35%.
Analyst Ratings Changes
A number of research analysts recently issued reports on the company. Cantor Fitzgerald restated an “overweight” rating and set a $284.00 price target (up from $229.00) on shares of Oracle in a research note on Friday, September 11th. Scotiabank cut their price target on Oracle from $241.00 to $215.00 and set a “sector outperform” rating on the stock in a research report on Wednesday, September 9th. Stifel Nicolaus reduced their price objective on Oracle from $220.00 to $200.00 and set a “buy” rating for the company in a research note on Friday, September 11th. CLSA initiated coverage on shares of Oracle in a report on Monday, July 20th. They issued a “hold” rating and a $145.00 target price on the stock. Finally, DZ Bank reiterated a “buy” rating on shares of Oracle in a research report on Thursday, September 17th. One research analyst has rated the stock with a Strong Buy rating, thirty-five have issued a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $249.52.
Check Out Our Latest Research Report on ORCL
Oracle News Roundup
Here are the key news stories impacting Oracle this week:
- Positive Sentiment: Oracle announced new Fusion Claw-powered agentic HR applications and an AI Agent Studio for building industry-specific agents. The products could strengthen Oracle’s applications business, increase customer productivity and support additional cloud demand. Oracle Introduces Claw-Powered Fusion Agentic Applications for HR
- Positive Sentiment: Southwest General is expanding its use of Oracle Health and Fusion Cloud products, providing evidence of continued adoption across healthcare, finance and operations. Southwest General Expands Relationship with Oracle
- Positive Sentiment: Oracle’s partnership with AstraZeneca to apply AI and real-world data to clinical-trial recruitment expands its healthcare opportunity beyond data-center infrastructure. However, the agreement is exploratory and may take time to generate material revenue. Oracle and AstraZeneca Partner to Advance AI-enabled Healthcare Innovation
- Neutral Sentiment: Oracle is benefiting from strong AI-cloud enthusiasm, including reports that Nvidia could be helping support financing for Oracle’s data-center buildout. The potential arrangement could ease near-term funding pressure, but it also highlights concerns about Oracle’s leverage, credit rating and dependence on outside financing. TD Cowen Thinks Nvidia Is Helping Oracle Get Its Data Centers Financed
- Negative Sentiment: The main investor concern is that Oracle’s cloud backlog has risen above $664 billion while free cash flow remains deeply negative. Analysts are questioning when the buildout will begin generating cash and whether the valuation adequately compensates investors for execution and financing risks. Oracle’s Growth to Valuation Mismatch is Less and Less Compelling
- Negative Sentiment: Coverage also points to potential customer-concentration and contract risks, including concerns that a significant portion of the backlog may be tied to OpenAI. Comparisons with Salesforce and Microsoft emphasize that Oracle’s faster cloud growth comes with considerably heavier capital spending and debt. Oracle vs. Microsoft: Which Is the Better AI Cloud Stock to Own
- Negative Sentiment: Reports that Oracle is invoking force majeure or reassessing elements of its massive data-center plans reinforce worries about construction delays, power availability and the ability to execute its AI infrastructure commitments. Oracle Calls Force Majeure Already?
Insider Buying and Selling at Oracle
In related news, Director Stephen H. Rusckowski purchased 25,000 shares of the business’s stock in a transaction dated Tuesday, September 29th. The stock was acquired at an average price of $139.35 per share, for a total transaction of $3,483,750.00. Following the completion of the purchase, the director directly owned 25,390 shares of the company’s stock, valued at $3,538,096.50. This trade represents a 6,410.26% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Maria Smith sold 2,631 shares of the company’s stock in a transaction that occurred on Tuesday, September 22nd. The stock was sold at an average price of $151.70, for a total value of $399,122.70. Following the sale, the executive vice president owned 64,357 shares of the company’s stock, valued at $9,762,956.90. This trade represents a 3.93% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 36,075 shares of company stock worth $5,342,123. 38.40% of the stock is currently owned by insiders.
About Oracle
Oracle Corporation (NYSE: ORCL) is a global technology company that develops enterprise software, cloud infrastructure and database technologies. Its products help organizations store, manage, analyze and secure data, while supporting business operations across industries and geographies.
The company’s offerings include Oracle Database, Java, Oracle Cloud Infrastructure and a broad portfolio of cloud-based applications. These applications serve functions such as enterprise resource planning, financial management, human resources, supply-chain management, customer experience and industry-specific operations.
Recommended Stories
- Five stocks we like better than Oracle
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL – Free Report).
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.
